These differences are reflected in key biochemical, biophysical, and functional traits, including immunoreactivity, protease resistance, size, aggregation dynamics, and toxicity, offering novel insights into the differential toxicity of tau oligomers in AD pathogenesis. The gene discussed is MAPT; the disease is Alzheimer disease.